12113076

Source:http://linkedlifedata.com/resource/pubmed/id/12113076

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0085101, umls-concept:C0205373, umls-concept:C0376315, umls-concept:C0443324, umls-concept:C0920425, umls-concept:C1548559
pubmed:issue	4
pubmed:dateCreated	2002-7-12
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101123358
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, http://linkedlifedata.com/resource/pubmed/chemical/Myeloablative Agonists, http://linkedlifedata.com/resource/pubmed/chemical/Peptides
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	1473-7140
pubmed:author	pubmed-author:BéhéM PMP, pubmed-author:BehrT MTM
pubmed:issnType	Print
pubmed:volume	1
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	501-5
pubmed:dateRevised	2007-6-7
pubmed:meshHeading	pubmed-meshheading:12113076-Antibodies, pubmed-meshheading:12113076-Dose-Response Relationship, Drug, pubmed-meshheading:12113076-Humans, pubmed-meshheading:12113076-Lymphoma, Non-Hodgkin, pubmed-meshheading:12113076-Myeloablative Agonists, pubmed-meshheading:12113076-Peptides, pubmed-meshheading:12113076-Radioimmunotherapy, pubmed-meshheading:12113076-Survival Rate
pubmed:year	2001
pubmed:articleTitle	Radioimmunotherapy versus traditional, nontargeted forms of systemic cancer treatment.
pubmed:publicationType	Editorial